Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
about
Somatostatin analogues for thyroid associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyCorticosteroids, somatostatin analogous or orbital radiotherapy for thyroid-associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyAcute thyroid eye disease (TED): principles of medical and surgical managementThe evaluation and treatment of graves ophthalmopathyHyperthyroidismGraves' ophthalmopathyRadiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy?Update on the medical treatment of Graves' ophthalmopathyAssessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.Selenium, selenoproteins and the thyroid gland: interactions in health and disease.Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.37-year-old woman with palpitations and fatigueThe role of serum C-reactive protein measured by high-sensitive method in thyroid disease.Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.Randomized controlled trial of rituximab in patients with Graves' orbitopathyBlood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis.Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective StudyAssessing Graves' ophthalmopathy-specific quality of life in Korean patients.The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyTSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathyThyroid associated orbitopathy: Understanding pathophysiology.Comparative evaluation of oculometric variables in Graves' ophthalmopathy.Update on thyroid eye disease and management.Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.Caruncle excision to treat epiphora caused by caruncle swelling in patients with active Graves' ophthalmopathy: case series.Emerging pharmacotherapy for treatment of Graves' diseaseOrbital decompression in thyroid eye disease.Imaging in Graves' orbitopathy.Elevated percentage of HLA-DR⁺ and ICAM-1⁺ conjunctival epithelial cells in active Graves' orbitopathy.Dose of intravenous steroids and therapy outcome in Graves' orbitopathy.
P2860
Q24195117-0EEAB6A3-031A-415C-9F31-F1821D3ECE89Q24202845-C017B255-266A-4AAF-895D-7A8C7B19A913Q24234896-D49479F6-BDC3-4A62-B4A3-21A1FAF0C7E0Q24235160-3590C9CE-22DF-4F7D-B8A2-8462A3838754Q26827429-9D8AE9C9-AD95-4EE8-AE05-77498588A7C8Q26862144-DC3576FC-84DC-4F25-9937-DE6A883D8537Q27690661-4EB766A7-8141-4C1B-9E76-FDD268286EB8Q28274196-B0AB0D6B-5D12-4B32-94F0-3BCC53A267E3Q30368547-FD7CAD75-B1B6-4001-8025-D1D1FCBB9ED8Q30413598-F8677097-4CB9-4AAC-B041-6185F99A5847Q30883875-7FF3E0AA-D3E8-4E8D-B9A9-81D5C182E81EQ31047067-F418059E-D495-457B-8F76-61A8200CF4C9Q33348029-94CB7BCF-309B-48BB-9DE2-745C1E7E6ACCQ33584454-8E3ED29F-3838-4098-8906-29687B2F06D5Q33735061-04A219D2-7910-4AA4-A95F-5405DA7779B8Q33774785-CCC64DF6-A34D-4CD2-84D0-157C8FFC95D0Q34200995-94ED920F-12DE-4AF2-8DF4-152B04AAB16FQ34225316-B5EF0A76-7872-4389-BFEA-F5FD8F67B73FQ34369480-E99EB33E-E042-4D28-85B5-E73F97314D39Q34450970-D5D49A4C-A313-40BC-B806-D61D230603D9Q34573865-BE888CF1-5257-4C2C-9670-690E415260B8Q35055076-906CA73D-9840-4E09-B42F-B1E7CC5A6803Q35055124-7E2C4BD5-102C-45DC-98E2-1A3E5B80BE08Q35364814-3060BA17-C995-44C9-A2F2-407882CDE5F8Q35808258-1C92D116-3E95-42B2-B706-B3FC41275629Q35843186-A58CC3E4-83FB-4C22-BBE7-FF3F3E33B6ACQ35886822-57C17F18-73E5-49BC-AE7F-A70F04E390E9Q36811289-1F98052A-D130-44A6-A3C4-3ADD4416EA0CQ36965291-C7C7C98E-9C8D-4C09-AA7E-6A37482CEA3FQ37026793-27A374B0-3E7F-41DD-83DC-0F4CCD69F822Q37059979-1DEB2EE1-3068-43C1-AC5D-87635420BE5DQ37349554-14B79C68-DFB5-4938-8B95-217C98A08670Q37406589-20D5196C-40D0-45C4-9AA0-915126BDE169Q37460205-E77C2466-6CAE-4127-A97F-AF0FF1D0596BQ37485896-070FCAE3-F0B6-4E78-A3AA-10873C799AE4Q37515491-666497E2-919D-419C-8379-DEA55F96527BQ37556318-C5FE22A4-53E9-4877-A074-74167A1E8811Q37617385-D818C678-E56D-44D4-9C0B-4A4017C37DEEQ37670358-0C2BDF9E-E998-43CB-B947-C4B1FEA312F0Q37982965-210494A2-EC29-4B8E-9DCD-0DEFE7B3E63A
P2860
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus statement of the Eur ...... gement of Graves' orbitopathy.
@en
Consensus statement of the European group on Graves' orbitopathy
@nl
type
label
Consensus statement of the Eur ...... gement of Graves' orbitopathy.
@en
Consensus statement of the European group on Graves' orbitopathy
@nl
prefLabel
Consensus statement of the Eur ...... gement of Graves' orbitopathy.
@en
Consensus statement of the European group on Graves' orbitopathy
@nl
P2093
P356
P1433
P1476
Consensus statement of the Eur ...... gement of Graves' orbitopathy.
@en
P2093
Aldo Pinchera
Alison J Dickinson
Anja Eckstein
Antonella Boschi
Carol M Lane
Chantal Daumerie
Christopher Neoh
Claudio Marcocci
Georg von Arx
George J Kahaly
P304
P356
10.1089/THY.2007.0315
P577
2008-03-01T00:00:00Z